Skip to main content
. 2020 May 21;11(5):383. doi: 10.1038/s41419-020-2598-6

Fig. 5. SET8 downregulation was involved in high glucose-induced endothelial NLRP3 inflammasome activation via upregulation of MARK4 expression in HUVECs.

Fig. 5

a The effects of SET8 overexpression on high glucose-induced MARK4 and NLRP3 inflammasome protein expression in hyperglycaemic HUVECs. b The effects of SET8 overexpression on high glucose-induced MARK4 and NLRP3 inflammasome mRNA expression in hyperglycaemic HUVECs. c The effects of SET8 overexpression on high glucose-induced interleukin (IL)-1β and IL-18 mRNA expression in hyperglycaemic HUVECs. d The effects of shSET8 on MARK4 and NLRP3 inflammasome protein expression in HUVECs. e The effects of shSET8 on MARK4 and NLRP3 inflammasome mRNA expression in HUVECs. f The effects of shSET8 on IL-1β and IL-18 mRNA expression in HUVECs. (*P ≤ 0.001, **P ≤ 0.0001, compared with the control group; #P ≤ 0.001, ##P ≤ 0.0001, compared with the high glucose treatment group) g The effects of siMARK4 on shSET8-induced MARK4 and NLRP3 inflammasome protein expression in HUVECs. h The effects of siMARK4 on shSET8-induced MARK4, NLRP3 inflammasome, IL-1β and IL-18 mRNA expression in HUVECs. (*P ≤ 0.001, **P ≤ 0.0001, compared with the control group; #P ≤ 0.001, ##P ≤ 0.0001, compared with the shSET8 treatment group, n = 5/group).